Which specific AMED research project was Dr. Kei Kunimasa's project selected for in FY2026?

It was selected for the 'Innovative Cancer Medical Practical Application Research Project'.

What is the official title or position of Dr. Kei Kunimasa at the institute?

Dr. Kei Kunimasa serves as the Deputy Director of Respiratory Medicine.

In which year was the Osaka International Cancer Institute established?

The Osaka International Cancer Institute was established in the year 1959.

What is the core philosophy of the Osaka International Cancer Institute?

The philosophy is 'providing and developing advanced cancer medical care based on the patient's perspective'.

What role does the institute play as a prefectural designated cancer care hospital?

As a prefectural designated cancer care hospital, it supports cancer medical care in Osaka.

AI News NQ Analysis

Research Project by Dr. Kei Kunimasa, Deputy Director of Respiratory Medicine, Selected for AMED's FY2026 'Innovative Cancer Medical Practical Application Research Project'

NQ Score 0/100

N1 Content Completeness 5

Key facts

Research Project by Dr. Kei Kunimasa, Deputy Director of Respiratory Medicine, Selected for AMED's FY2026 'Innovative Cancer Medical Practical Application Research Project'
The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).
Source: PR TIMES
Date: Mon Apr 13 2026 14:00:01 GMT+0900 (Japan Standard Time)

Direct answer

The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).

Citation: Research Project by Dr. Kei Kunimasa, Deputy Director of Respiratory Medicine, Selected for AMED's FY2026 'Innovative Cancer Medical Practical Application Research Project' (Mon Apr 13 2026 14:00:01 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Mon Apr 13 2026 14:00:01 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).

AI Analysis

Frequently Asked Questions

Q: Which specific AMED research project was Dr. Kei Kunimasa's project selected for in FY2026?: A: It was selected for the 'Innovative Cancer Medical Practical Application Research Project'.
Q: What is the official title or position of Dr. Kei Kunimasa at the institute?: A: Dr. Kei Kunimasa serves as the Deputy Director of Respiratory Medicine.
Q: In which year was the Osaka International Cancer Institute established?: A: The Osaka International Cancer Institute was established in the year 1959.
Q: What is the core philosophy of the Osaka International Cancer Institute?: A: The philosophy is 'providing and developing advanced cancer medical care based on the patient's perspective'.
Q: What role does the institute play as a prefectural designated cancer care hospital?: A: As a prefectural designated cancer care hospital, it supports cancer medical care in Osaka.